Lara Longpre, CHIEF DEVELOPMENT OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 847 shares at $26.19 ($22K) on 2024-02-02, disclosed to the SEC on 2024-02-05.
Open-market sale of $22k MIRM by CHIEF DEVELOPMENT OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2024-01-09 | $29K | — | Filing → |
| MIRM | SELL | 2023-07-05 | $26K | — | Filing → |
| MIRM | SELL | 2021-10-01 | $19K | — | Filing → |